$BSX Q1 '25 Earnings Results & Recap
Boston Scientific posted Q1 adjusted EPS of $0.75, beating estimates of $0.67, and Q1 revenue of $4.57B exceeded estimates of $4.57B. The firm's full-year organic revenue growth guidance was raised to 12%-14%, while Q2 organic growth is expected to be 13%-15%.